top of page

Arcellx’s CMO gives an update on their BCMA program at the 2023 CAR-TCR Summit

Chris Heery describes the process relating to bridging therapy that enabled a partial clinical hold to lift.



Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page